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ABSTRACT: 3,6-Dimethoxy-2-(cycloamino)anilines undergo 4- or 6-electron 
oxidations to afford novel ring-fused halogenated benzimidazoles or 
benzimidazolequinones using H2O2/HCl or H2O2/HBr. Cl2 and Br2 are capable of the 
same oxidative transformation to the benzimidazolequinones. Labelling experiments 
indicate that water is necessary for oxidation of the para-dimethoxybenzenes to the 
corresponding quinones. 
 
The cleanest method of generating elemental chlorine and 
bromine in situ is to mix hydrogen peroxide with excess 
hydrochloric and hydrobromic acid respectively, since the only by-
product is water (Scheme 1).1,2 The intermediate is hypohalous acid 
(HOX), which is commonly used to disinfect water. The molecular 
halogen (X2) in water is in equilibrium with an acidic (HX) solution 
of HOX.3,4  
 
Scheme 1. Generation of X2 from H2O2/HX  
 
 
 
The HOX solution has been used in the electrophilic halogenation 
of many aromatics.2,5-8 On the other hand, H2O2 in trifluoroacetic 
acid (TFA) has traditionally been used to give ring-fused 
benzimidazoles from o-cyclic amine substituted anilines.9 Recently, 
methanesulfonic acid (0.5-1 equiv) has replaced TFA in H2O2-
mediated cyclizations to give alicyclic ring-fused benzimidazoles.10 
In comparison, the H2O2/HX system is relatively underutilized in the 
synthesis of heterocycles with H2O2/HBr used to catalyze the 
aziridination of alkenes with chloramine T.11 One-pot H2O2/HX-
mediated oxidative cyclization of o-cyclic amine substituted anilines 
with selective dichlorination and dibromination gave a series of five 
to eight-membered ring-fused benzimidazoles, generally in >80% 
yield (Scheme 2a).8 
 
 
 
 
 
 
Scheme 2. H2O2/HX in the Preparation of Benzimidazoles and 
Benzimidazolequinones  
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Skibo and co-workers popularized aziridinyl-substituted 
pyrrolo[1,2-a]benzimidazolequinones as bioreductive antitumor 
alternatives to the mitomycins,12 and other groups reported 
benzimidazolequinones with useful cytotoxicity,13-21 including 
specificity towards hypoxic tumor cells,18 NAD(P)H:quinone 
oxidoreductase 1 (NQO1)19 and Fanconi anemia cells.20,21  
When para-dimethoxybenzenes are precursors, a two-step HBr-
mediated demethylation to the hydroquinone followed by FeCl3-
mediated oxidation is used to give the 
benzimidazolequinone.10,14,18,19 One step conversion of para-
dimethoxybenzenes to the desired quinones has been effected with 
AgO,22 Ce(NH4)2(NO3)6 (CAN),13,23-25 CoF3,26 NBS with a catalytic 
amount of H2SO4,20,27 and PhI(OCOCF3)2 (PIFA).28 For one-step 
formation of quinones, H2O2/HX has advantages of high atom 
economy29 and low cost. The simultaneous halogenation on the 
aromatic or the quinone can be useful for further nucleophilic 
aromatic substitution14,15,30,31 and transition metal-catalyzed cross-
couplings,32,33 with the resultant functionalization significantly 
altering biological activity.14,15,21,30,31,33 There are reports of low to 
moderate yields of oxidative demethylation with dihalogenation 
giving 5,6-dichloro- and 5,6-dibromobenzimidazolequinones using 
aqua regia (HNO3/HCl (1:3))15,16 and HBr/NaBrO3, respectively.16 
However, the combination of 2-electron oxidation to the quinone 
with 4-electron oxidative cyclization in one-pot is unknown. Herein, 
we utilize H2O2/HX to carry out oxidative cyclization, aromatic 
  
halogenation, and oxidative demethylation to give a new series of 
ring-fused dihalogenated benzimidazolequinones in mostly high 
yields (Scheme 2b). In all but one system, the protocol is tunable by 
adjusting the [H2O2] to [HX] ratio with high yields of the 
dihalogenated ring-fused dimethoxybenzimidazoles obtained when 
the [H2O2] is higher. Furthermore, the halogenation is selective to 
the activated aromatic or quinone moiety when an additional fused 
aromatic ring is in place.  
Initially, 3,6-dimethoxy-2-(cycloamino)anilines 1a-1e were 
treated with higher amounts of H2O2 (10 equiv) relative to HX 
(5 equiv) to give, in mostly high yields and without the need for 
chromatography, novel ring-fused dimethoxy-substituted 
benzimidazoles via a 4-electron oxidative cyclization and 
dihalogenation (Scheme 3). 2-(Pyrrolidin-1-yl)aniline 1a and 2-
(piperidin-1-yl)aniline 1b were found to be consumed within 20 min 
in MeCN under reflux to give dichlorinated and dibrominated 
pyrrolo[1,2-a]benzimidazoles (2a, 3a) and pyrido[1,2-
a]benzimidazoles (2b, 3b) in yields of 80-92% (Scheme 3). For 
cyclizations of morpholine 1c, azepane 1d and azocane 1e using 
H2O2/HCl, some oxidation to the benzimidazolequinone was 
detected at reflux. [1,4]Oxazino[4,3-a]benzimidazole 2c, 
azepino[1,2-a]benzimidazole 2d, and azocino[1,2-a]benzimidazole 
2e were selectively formed in good to high yields (67-95%) by 
lowering the reaction temperature (from reflux to 40 °C or rt) and 
increasing the reaction time (from 20 min to 2-24 h). 
Benzimidazolequinone formation was not detected in the HBr-
mediated cyclizations of 1c, 1d and 1e at reflux, with 3c obtained in 
89% yield, while a 6 h reaction time afforded complete 
dibromination to give 3d and 3e in excellent yield (92 and 95%, 
respectively). X-ray crystal structures for the eight-membered 
dichlorinated and dibrominated adducts 2e and 3e were obtained due 
to similarities of respective NMR spectra. 
The utility of the H2O2/HX-mediated system was investigated 
using the more challenging 2-(3,4-dihydroisoquinolin-2(1H)-yl)-
3,6-dimethoxyaniline (THIQ substrate) 1f with potential for 
halogenation on the additional aromatic ring (Scheme 3). Upon 
treatment of 1f (0.07 M in MeCN) with H2O2 (10 equiv) and HBr (5 
equiv) at reflux for 20 min, oxidative cyclization was observed at the 
benzylic position to afford 3f in 73% yield. The isolation of 
dichlorinated analogue 2f proved challenging under the same 
conditions due to the greater reactivity of the H2O2/HCl system. The 
H2O2/HCl system could be tuned to deliver mono- or dichlorination. 
At room temperature and a 4.5 h reaction time, only 
monochlorination was observed, affording 4f in 60% yield, while 
reaction for 24 h afforded the dichlorinated product 2f in 51% yield. 
The site of monochlorination was confirmed by X-ray 
crystallography on 4f. 
 
 
 
 
 
 
 
Scheme 3. Synthesis of Dihalogenated Benzimidazoles using 
H2O2/HXa,b 
 
aConditions: 1a-1f (1.0 mmol), H2O2 (10 mmol), HX (5 mmol), 
MeCN (10 mL). bIsolated yields. c2 h, 40 °C. d24 h, rt. e5 h, 40 °C. 
f6 h.  gMeCN (15 mL), 24 h, rt. hMeCN (15 mL). iMeCN (15 mL), 
4.5 h, rt. X-ray crystal structures showing one of the two molecules 
in the asymmetric unit cell for 2e and 3e with thermal ellipsoids set 
at 40% probability (Figures S1 & S2), and for 4f thermal ellipsoids 
set at 40% probability. 
 
 
The room temperature reaction allowed reaction profiling by HPLC 
(Figure 1) with mass spectrometry detection of chlorinated aniline 
intermediate 1g, suggesting that chlorination of 1f occurs prior to 
oxidative cyclization. This observation may explain the selectivity, 
of other one-pot oxidative cyclizations to benzimidazoles with 
aromatic halogenations,8 which can now be assumed to be a 
consequence of the NH2 of the substrate strongly directing the initial 
electrophilic aromatic substitution. 
 
  
 
Figure 1. HPLC chromatograms as a function of time (t) for the 
reaction of 2-(3,4-dihydroisoquinolin-2(1H)-yl)-3,6-
dimethoxyaniline (1f) with H2O2 (10 equiv) and HCl (5 equiv) in 
MeCN (15 mL) at rt. ESI HRMS (Figure S3) was used to detect 4-
chloro-2-(3,4-dihydroisoquinolin-2(1H)-yl)-3,6-dimethoxyaniline 
(1g). 
 
To carry out the one-pot overall 6-electron oxidation, to afford 
dihalogenated quinones, conditions which favor X2 formation were 
employed (Schemes 1 and 4). H2O2 (50 equiv) and HCl (180 equiv) 
converted anilines 1a-1d into dichlorinated ring-fused 
benzimidazolequinones 5a-5d in moderate to high yields (62-80%) 
after 4 h in MeCN at 80 °C, while 5e was isolated in 54% yield. For 
the H2O2/HBr-mediated transformations, the high concentrations of 
HBr required for quinone formation made it desirable to perform 
brominations under solvent-free conditions (except for 6f, which 
necessitated the use of MeCN due to the lower solubility of 1f in 
HBr). Dibrominated analogues 6a-6e were obtained in high yield 
(67-92%) using H2O2 (60 equiv) in neat HBr (30 mL) under reflux 
for 12 h. Ring-fused dihalogenated benzimidazolequinones (Scheme 
4) were purified by flash column chromatography with the exception 
of dibrominated pyrrolo[1,2-a]benzimidazolequinones 6a, which 
was isolated cleanly without purification. X-ray crystal structures of 
7,8-dichloro-3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole-
6,9-dione (5c), dichlorinated and dibrominated pyrrolo[1,2-
a]benzimidazolequinones 5a and 6a, and azepino[1,2-
a]benzimidazolequinones 5d and 6d were obtained. Isolation of 
significant amounts of 9,10-dichloro-5,6-dihydrobenzimidazo[2,1-
a]isoquinoline-8,11-dione (5f) was however not possible by 
treatment of THIQ 1f with a high molar ratio of HCl relative to H2O2 
at reflux. The reaction gave mainly inseparable products with ESI 
HRMS (m/z 388.9-392.9) indicative of tetrachlorination (Figure S4). 
This led us to employ the relatively mild conditions of H2O2 (10 
equiv) and HCl (5 equiv) at rt, that allowed aromatic monochloride 
and dichloride 4f and 2f to be isolated in good yields after 4.5 and 
24 h, respectively (Scheme 3, Figure 1), with extension to 72 h 
giving benzimidazolequinone 5f in 56% isolated yield (Scheme 4, 
Figure S5 for the HPLC chromatographs). The structure of 5f was 
confirmed by X-ray crystallography. In contrast the dibrominated 
analogue 6f was isolated in 68% yield from a 7 h reflux in the 
presence of a large excess of HBr; overbromination adducts were not 
detected. This is in line with the greater reactivity of Cl2 relative to 
Br2 in electrophilic halogenation reactions.34 
 
 
Scheme 4. Synthesis of Dihalogenated Benzimidazolequinones 
using H2O2/HXa,b 
 
aConditions: For the synthesis of dichlorides 5a-5e: 1a-1e (1.0 
mmol), H2O2 (50 mmol), HCl (180 mmol), MeCN (10 mL), 4 h, 80 
°C. For the synthesis of dibromides 6a-6f: 1a-1f (1.0 mmol), H2O2 
(60 mmol), HBr (30 mL), 12 h, reflux. bIsolated yields. cH2O2 (10 
mmol), HCl (5 mmol), MeCN (15 mL), 72 h, rt. dHBr (135 mmol), 
MeCN (15 mL), 7h. X-ray crystal structures shown of 5a, 5c, 5d, 
5f, 6a, and 6d have thermal ellipsoids set at 40% probability. 
Crystal structure of 6a is one of the six molecules in the asymmetric 
unit cell (Figure S6). 
 
 
Due to the suspected high concentration of Cl2 or Br2 in the one-
pot 6-electron oxidative cyclizations with dihalogenation, we 
decided to investigate if the formation of ring-fused dihalogenated 
benzimidazolequinones could be effected by elemental X2, with or 
without water. Chlorine gas was bubbled into a solution of anilines 
1b-1e in MeCN containing added H2O (Table 1). Dichlorinated 
benzimidazolequinones 5b, 5c and 5d were isolated, but in lower 
yields in comparison to H2O2/HCl method, although 5e was given in 
a comparable yield of 58% in this 10 min reflux reaction. A 
comparative study, using 1c and Cl2 was carried out in an equivalent 
amount of water (10.75 mL) to the H2O2/HCl protocol, however the 
yield of 5c was decreased further from 54% to 47%. Thus, water is 
required but not to the extent of the H2O2/HCl method. Moreover, 
yields deteriorated when the Cl2 reaction was performed under 
anhydrous conditions with inseparable products given. Over-
  
N
N
Y
X
X
O
O
Me
Me
N
N
Y
X
X
O
Me
X X X
X 18O
H
N
N
Y
X
18O
X
X
H
- HX
- MeOH
N
N
Y
18O
X
X
- HX
- MeOH
N
N
Y
18O
X
X
18O
O
Me
O X
Me
O
Me
O
Me
H
+ H2O
chlorination of 1-methylnapthalene was observed by Johnson et al. 
when Cl2 was used under aprotic conditions.35 Higher yields (71-
90%) were achieved for the analogous one-pot transformation giving 
dibrominated benzimidazolequinones 6b, 6d and 6e using Br2 and 
H2O at 40 °C for 4 h, which is indicative of the greater control 
achieved with less reactive Br2 (that is not susceptible to further 
bromination). 
 
Table 1. Synthesis of Dihalogenated Benzimidazolequinones 
using Elemental Chlorine and Brominea,b 
 
 
 
 
aniline X Y n yield (%) 
1b Cl CH2 1 5b, 41 
1c Cl O 1 5c, 54 
1c Cl O 1  5c, 47c 
1d Cl CH2 2 5d, 71 
1e Cl CH2 3 5e, 58 
1b Br CH2 1 6b, 71 
1d Br CH2 2 6d, 90 
1e Br CH2 3 6e, 90 
aConditions: For synthesis of dichlorides: 1 (1.0 mmol), Cl2 
(50.0 mmol), H2O (1.8 mL), MeCN (10 mL), reflux, 10 min. For 
synthesis of dibromides: 1 (1.0 mmol), Br2 (50 mmol), H2O (1.8 
mL), MeCN (10 mL), 40 °C, 4 h. bIsolated yields. cH2O (10.75 mL). 
 
Finally we investigated the role of water in the quinone 
formation step. 7,8-Dihalo-6,9-dimethoxybenzimidazoles 2c and 
3b were respectively treated with Cl2 and Br2 (both 50 equiv), and 
H218O (100 equiv) in MeCN (Scheme 5). The formation of the 
doubly 18O-labelled dihalogenated benzimidazolquinones 7c and 
8b was confirmed by EI-MS (Figure S7 & S8). It follows that for 
both the Cl2 and Br2-mediated reactions, MeO-aryl bond cleavage 
occurred, and quinone formation did not proceed through the 
hydroquinone. A control experiment treating 7,8-dichloro-3,4-
dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole-6,9-dione 5c with 
H218O for 4 h indicated no exchange. 
In conclusion, H2O2/HX has led to an unprecedented one-pot 6-
electron oxidative transformation to yield a new series of ring-fused 
dihalogenated benzimidazolequinones. The elemental halogens 
(X2) generated in situ from H2O2/HX are shown to be the active 
species in the oxidative synthesis. When a higher molar ratio of 
H2O2 relative to HX is employed, the X2 concentration is lower, 
and the 4-electron oxidative cyclization is not accompanied by 
oxidation to the quinone, allowing the selective formation of a new 
series of ring-fused dihalogenated benzimidazoles. 
Scheme 5. Detecting the role of water in Quinone formation 
with proposed mechanisma  
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aReaction conditions: For dichloride 7c: 2c (0.07 mmol), Cl2 (3.40 
mmol), H218O (0.14 mL), dried MeCN (0.73 mL), reflux, 10 min. 
For dibromide 8b: 3b (0.04 mmol), Br2 (2.05 mmol), H218O (0.08 
mL), dried MeCN (1 mL), 40 °C, 4 h.  
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